Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations
about
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.Hepatitis B Serology in Patients with Rheumatic DiseasesHepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C.Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis.Liver Illness and Psoriatic Patients.Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management.Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases.Current evidence on the management of hepatitis B in pregnancy
P2860
Q33825391-51BD1962-4A93-48E1-A24C-B781512C620EQ37291847-2F92F80A-E9CE-4788-B31D-DEB32F561508Q38805093-F309D978-0390-4F8E-BCDA-6CDEF50DF3F7Q40045559-FEAC8EB9-031E-4618-BFA0-659CB3FB35A5Q42334045-C722D530-2736-410D-9781-B004F5B733DCQ45326378-181BC9B3-C5BF-4309-9C71-DDAE8B9D502BQ52618967-49F086C2-C0F9-4152-B447-85645D79C7F7Q52653387-6D3B1FDD-2DD8-4FF4-A00D-FB981B706AD6Q54254957-2386CAD3-68EB-4B28-8035-7A97CBAF6628Q54279289-AF603042-2AAC-4D0E-91DE-07822836FC29Q55005117-A0AAC723-B316-4A88-BF9D-3B15D0B98D04Q57491228-A8FAA7A6-C3ED-4DA2-A893-6CA3CE7B14D9
P2860
Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Management of hepatitis B reac ...... ate on current recommendations
@ast
Management of hepatitis B reac ...... ate on current recommendations
@en
Management of hepatitis B reac ...... ate on current recommendations
@nl
type
label
Management of hepatitis B reac ...... ate on current recommendations
@ast
Management of hepatitis B reac ...... ate on current recommendations
@en
Management of hepatitis B reac ...... ate on current recommendations
@nl
prefLabel
Management of hepatitis B reac ...... ate on current recommendations
@ast
Management of hepatitis B reac ...... ate on current recommendations
@en
Management of hepatitis B reac ...... ate on current recommendations
@nl
P2860
P3181
P356
P1476
Management of hepatitis B reac ...... ate on current recommendations
@en
P2093
Fernando Bessone
Melisa Dirchwolf
P2860
P304
P3181
P356
10.4254/WJH.V8.I8.385
P407
P577
2016-03-18T00:00:00Z